Studies on the neuroendocrine role of serotonin

Danish Medical Bulletin

Volumn 54, Issue 4, 2007, Pages 266-288

  Jørgensen, Henrik Stig ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; AZASETRON; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYANOPINDOLOL; MESSENGER RNA; METERGOLINE; METHYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; OXYTOCIN; PROLACTIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 7 RECEPTOR; VASOPRESSIN;

ADENOHYPOPHYSIS; BLEEDING; BRAIN METABOLISM; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DEHYDRATION; DORSAL RAPHE NUCLEUS; DRUG RECEPTOR BINDING; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN SITU HYBRIDIZATION; IN VITRO STUDY; MICRODIALYSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PROLACTIN RELEASE; RADIOIMMUNOASSAY; RECEPTOR AFFINITY; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SEROTONINERGIC NERVE CELL; STRESS; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; ANIMAL; CENTRAL NERVOUS SYSTEM; INTESTINE MUCOSA; METABOLISM; NEUROSECRETION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CENTRAL NERVOUS SYSTEM; HUMANS; INTESTINAL MUCOSA; NEUROSECRETORY SYSTEMS; SEROTONIN; STRESS;

EID: 39049161622     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (381)

1. Adell A, Casanovas JM, Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 1997; 36:735-741.
2. Advis JP, Simpkins JW, Bennett JP, Meltes J. Serotonergic control of prolactin release in male rats. Life Sci 1979: 24:359-365.
3. Aguilar E, Tena-Sempere M, Aguilar R, Gonzalez D, Pinilla L. Interactions between N-methyl-D-aspartate, nitric oxide and serotonin in the control of prolactin secretion in prepubertal male rats. Eur J Endocrinol 1997; 137:99-106.
4. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15:321-350.
5. Aguilera G, Milian MA, Hauger RL, Call KJ. Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues. Ann N Y Acad Sci 1987; 512:48-66.
6. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000; 96:23-29.
7. Aguilera C, Rabadan-Diehl C, Nikodemova M. Regulation of pituitary corticotropin releasing hormone receptors. Peptides 2001; 22:769-774.
8. Anderson SM, Kant GJ, De Souza EB. Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors. Pharmacol Biochem Behav 1993; 44:755-761.
9. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7:351-378.
10. Antoni FA, Holmes MC, Makara GB, Karteszi M, Laszlo FA. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides 1984; 5:519-522.
11. Assenmacher I, Barbanel G, Gaillet S, Givalois L, Ixart G, Malaval F, Mekaouche M, Siaud P, Szafarczyk A. Central regulation of ACTH release in stress. Ann N Y Acad Sci 1995; 771:41-54.
12. Aubry JM, Bartanusz V, Jezova D, Belin D, Kiss JZ. Single stress induces long-lasting elevations in vasopressin mRNA levels in CRF hypophysiotrophic neurones, but repeated stress is required to modify AVP immunoreactivity. J Neuroendocrinol 1999; 11:377-384.
13. Aulakh CS, Mazzola-Pomietto P, Hill JL, Murphy DL. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2.5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. J Pharmacol Exp Ther 1994; 271:143-148.
14. Aulakh CS, Wozniak KM, Hill JL, Devane CL, Tolliver TJ, Murphy DL. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 1988; 48:401-406.
15. Azmitia E (1987). The CNS Serotonergic system: Progression toward a collaborative organization. In: Psychopharmacology: The third generation of progress. Meltzer HY (editor). New York: Raven Press. pp. 61-73.
16. Azmitia E, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978; 179:641-667.
17. Bachy A, Heaulme M, Giudice A, Michaud JC, Lefevre IA, Souilhac J, Manara L, Emerit MB, Gozlan H, Hamon M SR. 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. Eur J Pharmacol 1993; 237:299-309.
18. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/ corticosterone responses. Behav Brain Res 1996a: 73:277-280.
19. Bagdy G. Studies on the sites and mechanisms of 5-HT1A receptor-mediated in vivo actions. Acta Physiol Hung 1996b; 84:399-401.
20. Bagdy G, Makara GB. Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 1994; 134:1127-1131.
21. Bagdy G, Makara GB. Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur J Pharmacol 1995; 275:301-305.
22. Bagdy G, Sved AF, Murphy DL, Szemeredi K. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Eur J Pharmacol 1992; 210:285-289.
23. Balsa JA, Sanchez FF, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide. Neuroendocrinology 1998; 68:326-333.
24. Barofsky AL, Taylor J, Massari VJ. Dorsal raphe-hypothalamic projections provide the stimulatory serotonergic input to suckling-induced prolactin release. Endocrinology 1983; 113:1894-1903.
25. Barreca T, Corsini G, Cataldi A, Garibaldi A, Cianciosi P, Rolandi E, Franceschini R. Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patients. Biomed Pharmacother 1996; 50:512-514.,
26. Bartanusz V, Aubry JM, Jezova D, Baffi J, Kiss JZ. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 1993; 58:625-629.
27. Baumann MH, Rothman RB. Repeated cocaine administration reduces 5-HT1A-mediated prolactin secretion in rats. Neurosci Lett 1995: 193:9-12.
28. Baylis PH, Robertson GL. Rat vasopressin response to insulin-induced hypoglycemia. Endocrinology 1980; 107:1975-1979.
29. Beaulieu S, Di Paolo T, Barden N. Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology 1986; 44:247-254.
30. Bennett JL, Aghajanian GK. d-LSD binding to brain homogenates: possible relationship to serotonin receptors. Life Sci 1974; 15:1935-1944.
31. Benveniste H, Huttemeier PC. Microdialysis - theory and application. Prog Neurobiol 1990; 35:195-215.
32. Bluet Pajot MT, Mounier F, di Sciullo A, Schmidt B, Kordon C. Differential sites of action of 8OHDPAT, a 5HT1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinology 1995: 61:159-166.
33. Bockaert J, Claeysen S, Compan V, Dumuis A. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:39-51.
34. Bockaert J. Sebben M, Dumuis A. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol 1990; 37:408-411.
35. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacology 1994; 33:275-317.
36. Bogdanski DF, Pletscher A, Brodie BB, Udenfriend S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther 1956; 117:82-88.
37. Bohus B, Benus RF, Fokkema DS, Koolhaas JM, Nyakas C, van Oortmerssen GA, Prins AJ, de Ruiter AJ, Scheurink AJ, Steffens AB (1987). Neuroendocrine states and behavioral and physiological stress responses. De Kloet ER, Wiegant VM, de Wied D (editors). Amsterdam: Elsevier. pp. 57-70.
38. Bosch OJ, Kromer SA, Brunton PJ, Neumann ID. Release of oxytocin in the hypothalamic paraventricular nucleus, but not central amygdala of lateral septum in lactating residents and virgin intruders during maternal defence. Neuroscience 2004; 124:439-448.
39. Bourque CW. Ionic basis for the intrinsic activation of rat supraoptic neurones by hyperosmotic stimuli. J Physiol 1989; 417:263-277.
40. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25:563-576.
41. Brownfield MS, Greathouse J, Lorens SA, Armstrong J, Urban JH, Van de Kar LD. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988; 47:277-283.
42. Buckingham JC, Hodges JR. Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat. J Physiol (Lond) 1977; 272:469-479.
43. Buijs RM, Hermes MH, Kalsbeek A. The suprachiasmatic nucleus-paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog Brain Res 1998; 119:365-382.
44. Bulat M, Supek Z. The penetration of 5-hydroxytryptamine through the blood-brain barrier. J Neurochem 1967; 14:265-271.
45. Caldeira JC, Franci CR. Prolactin and corticosterone secretion in response to acute stress after paraventricular nucleus lesion by ibotenic acid. Brain Res Bull 2000; 52:483-489.
46. Caligaris L, Taleisnik S. Involvement of neurones containing 5-hydroxytryptamine in the mechanism of prolactin release induced by oestrogen. J Endocrinol 1974; 62:25-33.
47. Calogero AE. Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Ann N Y Acad Sci 1995; 771:31-40.
48. Calogero AE, Bagdy G, Moncada ML, D'Agata R. Effect of selective serotonin agonists on basal, corticotrophin- releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol 1993; 136:381-387.
49. Calogero AE, Bagdy C, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 1990; 126:1888-1894.
50. Carlsson M, Eriksson E. A central serotonin receptor agonist, 8-hydroloxy-2-(di-n-propylamino) tetralin, has different effects on prolactin secretion in male and female rats. Acta Pharmacol Toxicol Copenh 1986; 58:297-302.
51. Carrasco GA, Van de Kar LD Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463:235-272.
52. Carter DA, Lightman SL. Modulation of oxytocin secretion by ascending noradrenergic pathways: sexual dimorphism in rats. Brain Res 1987; 406:313-316.
53. Chalmers DT, Kwak SP, Mansour A, Akil H, Watson SJ. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci 1993; 13:914-923.
54. Chalmers DT, Lopez JF, Vazquez DM, Akil H, Watson SJ. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology 1994: 10:215-222.
55. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995; 15:6340-6350.
56. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotrophin-releasing factor receptors: from molecular biology to drug design. TIPS 1996; 17:166-172.
57. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000: 14:139-151.
58. Chaouloff F. Laude D, Merino D, Serrurier B, Baudrie V, Elghozi JL, Duration of streptozotocin diabetes influences the response of hypothalamic scrotonin metabolism to immobilization stress. Neuroendocrinology 1989: 50:344-350.
59. Chowdrey HS, Larsen PJ, Harbuz MS, Jessop DS, Aguilera G, Eckland DJ, Lightman SL. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol 1995; 116:2417-2424.
60. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 1998; 851:311-335.
61. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252.
62. Cleare AJ, Forsling M, Bond AJ. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Int Clin Psychopharmacol 1998; 13:23-32.
63. Clemens JA. Effects of serotonin neurotoxins on pituitary hormone release. Ann N Y Acad Sci 1978; 305:399-410.
64. Clemens JA, Sawyer BD, Cerimele B. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology 1977; 100:692-698.
65. Clement HW, Kirsch M, Hasse C, Opper C, Gemsa D, Wesemann W. Effect of repeated immobilization on serotonin metabolism in different rat brain areas and on serum corticosterone. J Neural Transm 1998: 105:1155-1170.
66. Clement HW, Schafer F, Ruwe C, Gemsa D, Wesemann W. Stress-induced changes of extracellular 5-hydroxyindoleacetic acid concentrations followed in the nucleus raphe dorsalis and the frontal cortex of the rat. Brain Res 1993; 614:117-124.
67. Clineschmidt BV, Totaro JA, McGuffin JC, Pflueger AB. Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine). Eur J Pharmacol 1976; 35:211-214.
68. Cocchi D, Gil Ad I, Panerai AE, Locatelli V, Muller EE. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation. Neuroendocrinology 1977; 24:1-13.
69. Collu R, Du Rusisseau P, Tache Y. Role of putative neurotransmitters in prolactin, GH and LH response to acute immobilization stress in male rats. Neuroendocrinology 1979; 28:178-186.
70. Conde GL, Renshaw D, Lightman SL, Harbuz MS. Serotonin depletion does not alter lipopolysaccharide-incluced activation of the rat paraventricular nucleus. J Endocrinol 1999; 156:245-251.
71. Costall B, Naylor RJ. 5-HT3 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:27-37.
72. Cowen PJ, Anderson IM, Grahame-Smith DG. Neuroendocrine effects of azapirones. J Clin Psychopharmacol 1990; 10:21S-25S.
73. Critchley DJ, Childs KJ, Middlefell VC, Dourish CT. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635. Eur J Pharmacol 1994: 264:95-97.
74. Culman J, Kvetnansky R, Torda T, Murgas K Serotonin concentration in individual hypothalamic nuclei of rats exposed to acute immobilization stress. Neuroscience 1980; 5:1503-1506.
75. Dahlström A, Fuxe K. Evidence for the existence of mooamine-containing neurons in the central nervous system. Acta Physiol Scand 1964: 62:1-55.
76. Day HE, Greenwood BN, Hammack SE, Watkins LR, Fleshner M, Maier SF, Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol 2004; 474;364-378.
77. de Goeij DC, Jezova D, Tilders FJ. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 1992; 577:165-168.
78. De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995; 20:789-819.
79. De Souza EB, Van Loon GR. Brain serotonin and catecholamine responses to repeated stress in rats. Brain Res 1986; 367:77-86.
80. Demarest KT, Moore KE, Riegle GD. Acute restraint stress decreases dopamine synthesis and turnover in the median eminence: a model for the study of the inhibitory neuronal influences on tuberoinfundibular dopaminergic neurons. Neuroendocrinology 1985; 41:437-444.
81. Di Renzo G, Amoroso S, Taglialatela M, Canzoniero, L, Basile V, Fatatis A, Annunziato L. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 1989: 162:371-373.
82. di Sciullo A. Bluet Pajot MT. Mounier F. Oliver C. Schmidt B. Kordon C. Changes in anterior pituitary hormone levels after serotonin IA receptor stimulation. Endocrinology 1990: 127:567-572.
83. Dieterich KD, Lehnert H, De Souza EB. Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 1997: 105:65-82.
84. Dryden S, McCarthy HD, Malabu UH, Ware M, Williams G. Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake. Peptides, 1993: 14:791-796.
85. Dumuis A. Sebben M, Bockaert J. The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 1989: 340:403-410.
86. Dunlop J, Sabb AL, Mazandarani H, Zhang J, Kalgaonker S, Shukhina E, Sukoff S. Vogel RL, Stack C, Schechter L, Harrison BL, Rosenzweig-Lipson S. WAY-163909 ((7bR,10aR)-l.2.3.4,8,9,10.10a-octahydro-7bH-cyclopenta- [b][1.4]diazepino[ 6,7,1 hi]indole); A Novel 5-HT2C Receptor Selective Agonist with Anorectic Activity. J Pharmacol Exp Ther 2005.
87. Dunn AJ. Stress-related changes in cerehral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone. J Neurochem 1988; 51:406-412.
88. Dunn AJ, Berridge CW. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 1987; 27:685-691.
89. Dunn AJ, Welch J. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J Neurochem 1991; 57:1615-1622.
90. Ebner K, Worjak CT, Landgraf R, Engelmann M. Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles. Horm Behav 2005; 47:14-21.
91. Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Wong EH. RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 1993; 110:119-126.
92. Eglen RM, Bonhaus DW, Johnson LG, Leung E, Clark RD. Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol 1995; 115:1387-1392.
93. Engelmann M, Ebner K, Landgraf R, Holsboer F, Wotjak CT. Emotional stress triggers intrahypothalamic but not peripheral release of oxytocin in male rats. J Neuroendocrinol 1999; 11:867-872.
94. Engelmann M, Ebner K, Landgraf R, Wotjak CT. Swim stress triggers the release of vasopressin within the suprachiasmatic nucleus of male rats. Brain Res 1998; 792:343-347.
95. Engelmann M, Wotjak CT, Ebner K, Landgraf R. Behavioural impact of intraseptally released vasopressin and oxytocin in rats. Exp Physiol 2000; 85 Spec No: 125S-130S.
96. Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 1996; 20:341-358.
97. Erlander MG, Lovenberg TW, Baron BM, de Lecea L, Danielson PE, Racke M, Slone AL, Siegel BW, Foye PE, Cannon K, et al. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. PNAS 1993; 90:3452-3456.
98. Falke N. Modulation of oxytocin and vasopressin release at the level of the neurobypophysis. Prog Neurobiol 1991; 36:465-484.
99. Faull CM, Charlton JA, Butler TJ, Baylis PH. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat. J Endocrinol 1993; 139:77-87.
100. Feldman S, Newman ME, Gur E, Weidenfeld J. Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses. Neuroreport 1998; 9:2007-2009.
101. Feldman S, Newman ME, Weidenfeld J. Effects of adrenergic and serotonergic agonists in the amygdala on the hypothalamo-pituitary-adrenocortical axis. Brain Res Bull 2000; 52:531-536.
102. Feldman S, Weidenfeld J. The excitatory effects of the amygdala on hypothalamo- pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res Bull 1998; 45:389-393.
103. Feldman S, Weidenfeld J. Involvement of endogeneous glutamate in the stimulatory effect of norepinephrine and serotonin on the hypothalamo -pituitary-adrenocortical axis. Neuroendocrinology 2004; 79:43-53.
104. Ferris CF, Melloni JR, Koppel G, Perry KW, Fuller RW, Delville Y. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci 1997; 17:4331-4340.
105. Fessler RG, Deyo SN, Meltzer HY, Miller RJ. Evidence that the medial and dorsal raphe nuclei mediate serotonergically-incluced increases in prolactin release from the pituitary. Brain Res 1984; 299:231-237.
106. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R. Laporte AM, Gozlan H, Hamon M, Dourish CT. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 1996; 73:337-353.
107. Franco-Bourland RE. Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress. Neurochem Res 1998; 23:695-701.
108. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure. function, and regulation of secretion. Physiol Rev 2000; 80:1523-1631.
109. Fuller RW, Snoddy HD. Elevation of plasma corticosterone by swim stress and insulin- induced hypoglycemia in control and fluoxetine-pretreated rats. Endocr Res Common 1977; 4:11-23.
110. Fuller RW, Snoddy HD, Clemens JA. Elevation by fenfluramine of 3,4-dihydroxyphonylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats. Pharmacol Res Commun 1981; 13:275-280.
111. Fuxe K, Farnebo LO, Hamberger B, Ogren SO. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad Med J 1975; 51 Suppl 1:35-45.
112. Fuxe K, Wikstrom AC, Okret S, Agnati LF, Harfstrand A, Yu ZY, Granholm, L, Zoli M, Vale W. Gustafsson JA. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985; 117:1803-1812.
113. Fyhrquist F, Tikkanen I, Linkola J. Plasma vasopressin concentration and renin in the rat: effect of hydration and hemorrhage. Acta Physiol Scand 1981; 113:507-510.
114. Gaddum JH, Picarelli ZP. Two kinds of tryptamine receptor. Br J Pharmacol 1957; 12:323-328.
115. Gala RR, Peters JA, Pieper DR, Campbell MD. Influence of adrenergic antagonists and apomorphine on prolactin release induced by serotonergic antagonists in the monkey. Life Sci 1978; 22:25-30.
116. Garcia-Garcia L, Fuentes JA, Manzanares J. Differential 5-HT-mediated regulation of stress-induced activation of proopiomelanocortin (POMC) gene expression in the anterior and intermediate lobe of the pituitary in male rats. Brain Res 1997; 772:115-120.
117. Garrido MM, Fuentes JA, Manzanares J. Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions. Life Sci 2002: 70:2953-2966.
118. Garthwaite TL, Hagen TC. Evidence that serotonin stimulates a prolactin-releasing factor in the rat. Neuroendocrinology 1979; 29:215-220.
119. Gartside SE, Cowen PJ. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors. Eur J Pharmacol 1990; 179:103-109.
120. Gartside SE, Cowen PJ, Hjorth S. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. Eur J Pharmacol 1990; 191:391-400.
121. Gartside SE, Cowen PJ, Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 1992a; 31:9-14.
122. Gartside SE, Ellis PM, Sharp T, Cowen PJ. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur J Pharmacol 1992b; 221:27-33.
123. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJ, Hartig PR, Branchek TA, et al. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 1995; 14:2806-2815.
124. Gibbs DM. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. Life Sci 1984; 35:487-491.
125. Gibbs DM. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinology 1986; 11: 131-139.
126. Gibbs DM, Vale W. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 1993; 280:176-179.
127. Gil Ad I, Zambotti F, Carruba MO, Vicentini L, Muller EE. Stimulatory role for brain serotoninergic system on prolactin secretion in the male rat. Proc Soc Exp Biol Med 1976; 151:512-518.
128. Gilbert F, Dourish CT, Brazell C, McClue S, Stahl SM. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in ram Psychoneuroendocrinology 1988; 13:471-478.
129. Givalois L, Becq H, Siaud P. Ixart G, Assenmacher I, Barbanel G. Serotoninergic and suprachiasmatic nucleus involvement in the corticotropic response to systemic endotoxin challenge in rats. J Neuroendocrinol 1999: 11:629-636.
130. Glennon RA, Westkaemper RB, Bartyzel P (1991). Medicinal chemistry of serotonergic agents. In: Serotonin receptor subtypes. Basic and clinical aspects. Peroutka SJ (editor). New-York: Wiley-Liss. pp. 19-64.
131. Gold PW, Kling MA, Whitfield HJ, Rabin D, Margioris A, Kalogeras K, Demitrack M, Loriaux DL, Chrousos GP. The clinical implications of corticotropin-releasing hormone. Adv Exp Med Biot 1988; 245:507-519.
132. Graeff FC, Guimaraes FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 129-141.
133. Greuel JM, Glaser T. The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol 1992; 211:211-219.
134. Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco, GA. Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl) 2004.
135. Groenink L, Mos J, Van der Gugten J, Olivier B. The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones. Pharmacol Biochem Behav 1996; 55:393-308.
136. Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br J Pharmacol 1996: 117:657-666.
137. Haas DA, George SR. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res 1999; 461:230-237.
138. Hamon M, Bourgoin S, el Mestikawy S, Goetz C (1982). Central serotonin receptors. Oxford: Blackwell Science. pp. 107-143.
139. Harbuz MS, Chalmers J, De Souza L, Lightman SL. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res 1993; 609:167-173.
140. Harbuz MS, Chowdrey HS, Jessop DS, Biswas S, Lightman SL. Role of catecholamines in mediating messenger RNA and hormonal responses to stress. Brain Res 1991; 551:52-57.
141. Hartig PR. Molecular biology of 5-HT receptors. TIPS 1989; 10:64-69.
142. Hashimoto K, Murakami K, Takao T, Makino S, Sugawara M, Ota Z. Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat. Acta Med Okayama 1989; 43:161-167.
143. Hashimoto K, Ohno N, Murakami K, Kageyama J, Aoki Y, Takahara J. The effect of serotonin agonist 1-(trifluoromethylphenyl)-piperazine on corticotropin releasing factor and arginine vasopressin in rat hypothalamic nuclei. Endocrinol Jpn 1982; 29:383-388.
144. Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S, Ota Z. Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul Pept 1988; 23:117-126.
145. Hensler JG. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 2003; 72:1665-1682.
146. Herdman JR, Delva NJ, Hockney RE, Campling GM, Cowen PJ. Neuro-endocrine effects of sumatriptan. Psychopharmacology (Berl) 1994; 113:561-564.
147. Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding. J Med Chem 1992; 35:4903-4910.
148. Higgins GA, Joharchi N, Sellers EM. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 1993; 264:1440-1449.
149. Hillhouse EW. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Endocrinol 1989; 122:713-718.
150. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsufmoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain. Nature 1998; 393:272-276.
151. Hollt V, Przewlocki R, Haarmann I, Almeida OF, Kley N, Millan MJ, Herz A. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. Neuroendocrinology 1986; 43:277-282.
152. Holmes MC, Di Renzo G, Beckford U, Gillham B, Jones MT. Role of serotonin in the control of secretion of corticotrophin releasing factor. J Endocrinol 1982; 93:151-160.
153. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circathan rhythm and stress. Brain Res Mol Brain Res 1995: 28:186-192.
154. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17:187-205.
155. Holsboer F, Gerken A, Stalla GK, Muller OA Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am J Psychiatry 1987; 144:229-231.
156. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 1995; 62:340-347.
157. Hoyer D Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 1988; 8:59-81.
158. Hoyer D (1989). 5-hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Peripheral actions of 5-HT. Fozard J (editor). Oxford: Oxford University Press. pp. 72-99.
159. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR. Mylecharane EJ, Saxena PR, Humphrey PP. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46:157-203.
160. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002: 71:533-554.
161. Husain MK, Manger WM, Rock TW, Weiss RJ, Frantz AG. Vasopressin release due to manual restraint in the rat: role of body compression and comparison with other stressful stimuli. Endocrinology 1979; 104:641-644.
162. Hyyppa M, Wurtman RJ. Biogenic amines in the pituitary gland: what is their origin and function? Pituitary indolamines. Prog Brain Res 1973: 39:211-215.
163. Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress. Neuroendocrinology 2001; 73:293-301.
164. Imaki T, Nahan JL, Rivier C, Sawchenko PE, Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 1991; 11:585-599.
165. Imaki T, Naruse M, Harada S, Chikada N, Nakajima K, Yoshimoto T, Demura H. Stress-induced changes of gene expression in the paraventricular nucleus are enhanced in spontaneously hypertensive rats. J Neuroendocrinol 1998; 10:635-643.
166. Iovino M, Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 1985; 113:99-103.
167. Isogawa K, Akiyoshi J, Hikichi T, Yamamoto Y, Tsutsumi T, Nagayama H. Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo. Neuropeptides 2000; 34:234-239.
168. Itof K, Helmreich DL, Lopez-Figueroa MO, Watson SJ. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 1999; 19:5464-5472.
169. Ixart G, Szafarczyk A, Malaval F, Asseninacher I. Impairment of the ether stress-induced ACTH surge in rats by ablation of the suprachiasmatic nuclei or by ip injections of chlorophenylalanine. Neuroendocrine Letters 1985; 7:171-174.
170. Jacobs BL, Azmitia E. Structure and function of the brain serotonin system. Physiol Rev 1992; 72:165-229.
171. Javed A, Kamradt MC, Van de Kar LD, Gray TS. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala. Neuroscience 1999; 90:851-858.
172. Jezova D, Skultetyova I, Tokarev DI, Bakos P, Vigas M. Vasopressin and oxytocin in stress. Ann N Y Acad Sci 1995: 771:192-203.
173. Jones MT, Hillhouse EW, Burden J. Effect on various putative neuro-transmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro-a model of the neurotransmitters involved. J Endocrinol 1976; 69:1-10.
174. Jorgensen, H. Thesis: Serotonergic regulation of pituitary ACTH secretion. 1-79. 1999. University of Copenhagen.
175. Jorgensen H, Kjaer A, Knigge U, Moller M, Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol 2003a; 15:564-571.
176. Jorgensen H, Kjaer A, Warberg J, Knigge U. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin. Neuroendocrinology 2001; 73:322-333.
177. Jorgensen H, Knigge U, Kjaer A, Moller M, Warberg J. Serotonergic Stimulation of Corticotropin-Releasing Hormone and Pro-Opiomelanocortin Gene Expression. J Neuroendocrinol 2002a; 14:788-795.
178. Jorgensen H, Knigge U, Kjaer A, Vadsholt T, Warberg J. Serotonergic involvement in stress-induced ACTH release. Brain Res 1998a; 811:10-20.
179. Jorgensen H, Knigge U, Kjaer A, Warberg J. Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion. Neuroendocrinology 1996; 64:329-336.
180. Jorgensen, H., Knigge, U., Kjaer, A., and Warberg, J. Stress-induced neurohypophysial hormone secretion is partly mediated by serotonergic neurons. International Union of Pharmacology IV, 112. 1998b.
181. Jorgensen H, Knigge U, Kjaer A, Warberg J. Adrenocorticotropic Hormone secretion in rats induced by stimulation with serotonergic compounds. J Neuroendocrinol 1999; 11:283-290.
182. Jorgensen H, Knigge U, Kjaer A, Warberg J. Serotonergic involvement in stress-induced vasopressin and oxytocin secretion. Eur J Endocrinol 2002b; 147:815-824.
183. Jorgensen H, Knigge U, Warberg J. Effect of serotonin, 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress. Neuroendocrinology 1992a; 56:371-377.
184. Jorgensen H, Knigge U, Warberg J. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5- hydroxytryptophan. Neuroendocrinology 1992b; 55:336-343.
185. Jorgensen H, Knigge U, Warberg J. Effect of selective serotonin receptor agonists on prolactin secretion in male rats. Neuroendocrinology 1993; 57:401-407.
186. Jorgensen H, Riis M, Knigge U, Kjaer A, Warberg J. Serotonergic receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol 2003b; 15: 1-8.
187. Kageyama K. Tozawa F, Horiba N, Watanobe H, Suda T. Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Neurosci Lett 1998; 243:17-20.
188. Kalsbeek A, Ruiter M, La Fleur SE, Van Heijningen C, Buijs RM. The diurnal modulation of hormonal responses in the rat varies with different stimuli. J Neuroendocrinol 2003; 15:1144-1155.
189. Kamberi IA, Mical RS, Porter JC. Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology 1971; 88:1288-1293.
190. Kant GJ, Mougey EH, Meyerhoff JL. Diurnal variation in neuroendocrine response to stress in rats: plasma ACTH, beta-endorphin, beta-LPH, corticosterone, prolactin and pituitary cyclic AMP responses. Neuroendocrinology 1986; 43:383-390.
191. Kasting NW. Simultaneous and independent release of vasopressin and oxytocin in the rat. Can J Physiol Pharmacol 1988; 66:22-26.
192. Kato Y, Nakai Y, Imura H, Chihara K, Ogo S. Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. J Clin Endocrinol Metab 1974; 38:695-697.
193. Kawakami M, Higuchi T, Matsuura M. Immobilization stress and prolactin secretion in male rats. Possible roles of dopamine and TRH. Neuroendocrinology 1979; 29:262-269.
194. Keit LC, Severs WB. Reduction in plasma vasopressin levels of dehydrated rats following acute stress. Endocrinology 1977; 100:30-38.
195. Kilpatrick GJ, Bunce KT, Tyers MB. 5-HT3 receptors (published erratum appears in Med Res Rev 1991 Mar; 11(2):237]. Med Res Rev 1990; 10:441-475.
196. Kilpatrick GJ, Jones BJ, Tyers MB. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 1987; 330:746-748.
197. King BH, Brazell C, Dourish CT, Middlemiss DN. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype. Neurosci Lett 1989; 105:174-176.
198. Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000; 22:148-162.
199. Kiss JZ, Kanyicska B, Nagy GY. The hypothalamic paraventricular nucleus has a pivotal role in regulation of prolactin release in lactating rats. Endocrinology 1986; 119:870-873.
200. Kjaer A, Knigge U, Bach FW, Warberg J. Histamine- and stress-induced secretion of ACTH and beta- endorphin: involvement of corticotropin-releasing hormone and vasopressin. Neuroendocrinology 1992; 56:419-428.
201. Kjaer A, Knigge U, Rouleau A, Garbarg M, Warberg J. Dehydration-induced release of vasopressin involves activation of hypothalamic histaminergic neurons. Endocrinology 1994a; 135:675-681.
202. Kjaer A, Knigge U, Warberg J. Involvement of oxytocin in histamine-and stress-induced ACTH and prolactin secretion. Neuroendocrinology 1995a; 61:704-713.
203. Kjaer A, Larsen PJ, Knigge U, Jorgensen H, Warberg J. Neuronal histamine and expression of corticotropin-releasing hormone, vasopressin and oxytocin in the hypothalamus: relative importance of H1 and H2 receptors. Eur J Endocrinol 1998: 139:238-243.
204. Kjaer A, Larsen PJ, Knigge U, Warberg J. Histaminergic activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 1994b; 135:1171-1177.
205. Kjaer A, Larsen PJ, Knigge U, Warberg J. Dehydration stimulates hypothalamic gene expression of histamine synthesis enzyme: importance for neuroendocrine regulation of vasopressin and oxytocin secretion. Endocrinology 1995b; 136:2189-2197.
206. Knigge U. Kjaer A, Larsen PJ, Jorgensen H, Bach FW. Moller M, Warberg J. Effect of histamine on gene expression and release of proopio-melanocortin-derived peptides from the anterior and intermediate pituitary lobes in conscious male rats. Neuroendocrinology 1995: 62:319-325.
207. Knigge U, Matzen S, Warberg J. Histaminergic mediation of the stress-induced release of prolactin in male rats. Neuroendocrinology 1998a; 47:68-74.
208. Knigge U, Sleimann I, Matzen S, Warberg J. Histaminergic regulation of prolactin secretion: involvement of serotoninergic neurons [published erratum appears in Neuroendocrinology 1989 Feb: 49(2):following 223]. Neuroendocrinology 1988b; 48:527-533.
209. Knigge U, Soe-Jensen P, Jorgensen H, Kjaer A, Moller M, Warberg J. Stress-induced release of anterior pituitary hormones: effect of H3 receptor-mediated inhibition of histaminergic activity or posterior hypothalamic lesion. Neuroendocrinology 1999: 69:44-53.
210. Koenig JI, Gudelsky GA, Meltzer HY. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 1987: 137:1-8.
211. Koenig JI, Meltzer HY, Gudelsky GA. 5-Hydroxytryptamine 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 1988: 29:711-715.
212. Koob GF, Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999: 848:141-152.
213. Kordon C, Blake CA, Terkel J, Sawyer CH. Participation of serotonin-containing neurons in the suckling- induced rise in plasma prolactin levels in lactating rats. Neuroendocrinology 1973; 13:213-223.
214. Kovacs KJ, Miklos IH, Bali B. GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis. Ann N Y Acad Sci 2004: 1018:466-476.
215. Krulich L. The effect of a serotonin uptake inhibitor (Lilly 110140) on the sercretion of prolactin in the rat. Life Sci 1975; 17:1141-1144.
216. Krulich L, Vijayan E, Coppings RJ, Giachetti A, McCann SM, Mayfield MA. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5- hydroxytryptamine and quipazine in the male rat. Endocrinology 1979; 105:276-283.
217. Lacau-Mengido IM, Libertun C, Becu-Villalobos D. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat. Neuroendocrinology 1996; 63:415-421.
218. Laflamme N, Bovetto S, Richard D, Rivest S. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus. Br J Pharmacol 1996; 117:1021-1034.
219. Lamberts SW, MacLeod RM. The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide. Endocrinology 1978; 103:287-295.
220. Landgraf R, Ludwig M. Vasopressin release within the supraoptic and paraventricular nuclei of the rat brain: osmotic stimulation via microdialysis. Brain Res 1991; 558:191-196.
221. Lanfumey L, Hamon M. 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:1-10.
222. Lanfumey L, Pardon MC, Laaris N, Joubert C, Hanoun N, Hamon M, Cohen-Salmon C. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 1999; 10:3369-3374.
223. Lang RE, Heil JW, Ganten D, Hermann K, Unger T, Rascher W. Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology 1983; 37:314-316.
224. Larsen PJ, Hay-Schmidt A, Wang N, Mikkelsen JD. Origin of projections from the midbrain raphe nuclei to the hypothalamic paraventricular nucleus in the rat: a combined retrograde and anterograde tracing study. Neuroscience 1996; 70:963-988.
225. Lawson DM, Gala RR. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats. Endocrinology 1975; 96:313-318.
226. Lawson DM, Gala RR. The interaction of dopaminergic and serotonergic drugs on plasma prolactin in ovariectomized, estrogen-treated rats. Endocrinology 1976; 98:42-47.
227. Lawson DM, Gala RR. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats. Endocrinology 1978; 102:973-981.
228. Leng G, Dyball RE, Luckman SM. Mechanisms of vasopressin secretion. Horm Res 1992; 37:33-38.
229. Levy AD, Li Q, Rittenhouse PA, Van de Kar LD. Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin. Neuroendocrinology 1993; 58:65-70.
230. Leysen JE. 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:11-26.
231. Li Q, Brownfield MS, Levy AD, Battaglia G. Cabrera TM, Van de Kar LD. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 1994: 36:300-308.
232. Liposits Z, Phelix V, Paull WK. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 1987: 86:541-549.
233. Lopez JF, Liberzon I, Vazquez DM, Young EA, Watson SJ. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol Psychiatry 1999; 45:934-937.
234. Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW, et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993; 11:449-458.
235. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain [published erratum appears in Proc Natl Acad Sci U S A 1995 Jun 6; 92(12):57591]. PNAS 1995; 92:836-840.
236. Lowy MT Meltzer HY. Stimulation of serum cortisol and prolactin secretion in humans by MK-212. a centrally active serotonin agonist. Biol Psychiatry 1988; 23:818-828.
237. Lu KH, Meites J. Effects of serotonin precursors and melatonin on serum prolactin release in rats. Endocrinology 1973; 93:152-155.
238. Ludwig M, Callahan MF, Neumann I, Landgraf R, Morris M. Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J Neuroendocrinol 1994; 6:369-373.
239. Luthin, D. R., Youngblood, K. L., Rabinovich, A., Brown, M. R., and May, J. M. Corticotropin releasing factor (CRF) mediates ACTH release and hypotension by two pharmacologically distinct CRF receptor subtypes. Society for Neuroscience 22[2], 1545. 1996.
240. Ma XM, Lightman SL, Aguilera G. Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint. Endocrinology 1999; 140:3623-3632.
241. Mansi JA, Rivest S, Drolet C. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology 1996; 137:4619-4629.
242. Maruyama M, Matsumoto H, Fujiwara K, Kitada C, Hinuma S, Onda H, Fujino M, Inoue K. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology 1999; 140:2326-2333.
243. Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol Pharmacol 1993; 43:313-319.
244. Mazzola-Pomietto P, Aulakh CS, Murphy DL. NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats. Eur J Pharmacol 1996; 308:329-333.
245. McCabe JT, Morrell JI, Ivell R, Schmale H, Richter D, Pfaff DW. In situ hybridization technique to localize rRNA and mRNA in mammalian neurons. J Histochem Cytochem 1986; 34:45-50.
246. McKinley MJ, Mathai ML, McAllen RM, McClear RC, Miselis RR, Pennington GL, Vivas L, Wade JD, Oldfield BJ. Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 2004; 16:340-347.
247. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000; 16:843-857.
248. Meltzer HY. Simonovic M. Gudelsky CA. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. Eur J Pharmacol 1983; 92:83-89.
249. Mendelson SD, McEwen BS. Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 1991; 54:454-461.
250. Meyerhoff JL, Mougey EH, Kant GJ. Paraventricular lesions abolish the stress-induced rise in pituitary cyclic adenosine monophosphate and attenuate the increases in plasma levels of proopiomelanocortin-derived peptides and prolactin. Neuroendocrinology 1987; 46:222-230.
251. Mezey E, Young WS3, Siegel RE, Kovacs K. Neuropeptides and neurotransmitters involved in regulation of corticotropin-releasing factor-containing neurons in the rat. Prog Brain Res 1987: 72:119-127.
252. Mikkelsen JD, Hay-Schmidt A, Kiss A. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors. Ann N Y Acad Sci 2004; 1018:65-70.
253. Mikkelsen JD, Jensen JB, Engelbrecht T, Mork A. D-fenfluramine activates rat oxytocinergic and vasopressinergic neurons through different mechanisms. Brain Res 1999; 851:247-251.
254. Milian MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille Girardon S, Verriele L, et al. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. J Pharmacol Exp Ther 1992; 262:451-463.
255. Minamitani N, Minamitani T, Lechan RM, Bollinger Gruber J, Reichlin S. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat. Endocrinology 1987; 120:860-867.
256. Miyata K, Ito H, Fukudo S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 1998; 274:G827-G831.
257. Monsma FJ, Jr., Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993; 43:320-327.
258. Mota A, Bento A, Penalva A, Pombo M, Dieguez C. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. J Clin Endocrinol Metab 1995; 80:1973-1977.
259. Nakagami Y, Suda T, Yajima F, Ushiyama T, Tomori N, Sumitomo T, Demura H, Shizume K. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Res 1986; 386:232-236.
260. Nash JF, Meltzer HY. Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat. J Pharmacol Exp Ther 1989; 249:236-241.
261. Neill JD. Effect of "stress" on serum prolactin and luteinizing hormone levels during the estrous cycle of the rat. Endocrinology 1970; 87:1192-1197.
262. Nelson DL. 5-HT5 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:53-58.
263. Nelson DL, Pedigo NW, Yamamura HI. Multiple 3H-5-hydroxytryptamine binding sites in rat brain. J Physiol Paris 1981; 77:369-372.
264. Neumann I, Ludwig M, Engelmann M, Pittman QJ, Landgraf R. Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 1993; 58:637-645.
265. Nishioka T, Anselmo-Franci JA, Li P, Callahan MF, Morris M. Stress increases oxytocin release within the hypothalamic paraventricular nucleus. Brain Res 1998; 781:56-60.
266. Nonaka KO. Involvement of 5-HT3 receptors in the prolactin release induced by immobilization stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23:497-503.
267. Ohi K, Mikuni M, Takahashi K. Stress adaptation and hypersensitivity in 5-HT neuronal systems after repeated foot shock. Pharmacol Biochem Behav 1989; 34:603-608.
268. Onaka T, Yagi K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats. Brain Res 1998; 788:287-293.
269. Orosco M, Nicolaidis S. Insulin and glucose-induced changes in feeding and medial hypothalamic monoamines revealed by microdialysis in rats. Brain Res Bull 1994: 33:289-297.
270. Osborne H, Przewlocki R, Hollt V, Herz A Release of beta-endorphin from rat hypothalamus in vitro. Eur J Pharmacol 1979; 55:425-428.
271. Oshima A, Flachskamm C, Reul JM, Holsboer F, Linthurst AC. Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activitv in mice chronically treated with the corticotropin-releasing hormone. receptor type 1 antagonist NBI 30775. Neuropsychopharmacology 2003; 28:2148-2159.
272. Ossowska G, Nowak G, Klenk-Majewska B, Danilczuk Z, Zebrowska-Lupina I. Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats. Pol J Pharmacol 2002; 54:89-93.
273. Owens MJ, Edwards E, Nemeroff CB. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary- adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. Eur J Pharmacol 1990; 190:113-122.
274. Page IH (1968). The brain and its serotonin. In: Serotonin. Chicago: Year book medical publishers. pp. 55-74.
275. Palkovits M. Anatomy of neural pathways affecting CRH secretion. Ann N Y Acad Sci 1987; 512:139-148.
276. Pan LH, Gilbert F. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology 1992; 56:797-802.
277. Paris JM, Lorens SA, Van de Kar LD, Urban JH, Richardson Morton KD, Bethea CL. A comparison of acute stress paradigms: hormonal responses and hypothalamic serotonin. Physiol Behav 1987; 39:33-43.
278. Parisi MN, Vitale ML, Villar MJ, Estivariz FE, Chiocclido SR, Tramezzani JH. Serotonergic terminals in the anterior hypothalamic nucleus involved in the prolactin release during suckling. Endocrinology 1997; 120:2404-2412.
279. Pazos A, Hoyer D, Palacios JM. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 1984; 106:539-546.
280. Pergola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 1993; 57:550-558.
281. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci 2004; 24:1305-1311.
282. Peroutka SJ, Howell TA. The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 1994; 33:319-324.
283. Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential binding of [3H]5- hydroxytryptamine, [3H]1ysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 1979; 16:687-699.
284. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993; 133:3058-3061.
285. Pilc A, Nowak JZ. Influence of histamine on the serotonergic system of rat brain. Eur J Pharmacol 1979; 55:269-272.
286. Pilotte NS, Porter JC. Dopamine in hypophysial portal plasma and prolactin in systemic plasma of rats treated with 5-hydroxytryptamine. Endocrinology 1981: 108:2137-2141.
287. Pinnock SB, Herbert J. Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. Eur J Neurosci 2001; 13:576-584.
288. Plotsky PM. Hypophysiotropic regulation of stress-induced ACTH secretion. Adv Exp Med Biol 1988; 245:65-81.
289. Plotsky PM, Bruhn TO, Vale W. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 1985; 117:323-329.
290. Pompeiano M, Palacios JM, Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 1994; 23:163-178.
291. Porter JC, Mical RS, Cramer OM. Effect of serotonin and other indoles on the release of LH, FSH, and prolactin. Gynecol Invest 1971; 2:13-22.
292. Prewitt CM, Herman JP. Hypothalamo-Pituitary-Adrenocortical Regulation Following Lesions of the Central Nucleus of the Amygdala. Stress 1997; 1:263-280.
293. Preziosi P. Serotonin control of prolactin release: an intriguing puzzle. TIPS 1983; 171-174.
294. Raghupathi RK, McGonigle P. Differential effects of three acute stressors on the serotonin 5- HT1A receptor system in rat brain. Neuroendocrinology 1997; 65:246-258.
295. Rainero I, Valfre W, Savi L, Gentile S, Pinessi L, Gianotti L, Arvat E, Ghigo E, Del Rizzo P, Calvelli P, Limone P. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine. J Endocrinol Invest 2001; 24:310-314.
296. Ramalho MJ, Reis LC, Antunes-Rodrigues J, Nonaka KO, De Castro e Silva. Reduced prolactin release during immobilization stress in thyrotoxic rats: role of the central serotoninergic system. Horm Metab Res 1995; 27:121-125.
297. Rapport MM, Green AA, Page IH. Serum vasoconstrictor (serotonin) IV. J Biol Chem 1948; 176:1243-1251.
298. Reeves WB, Bichet DG, Andreoli TE (1998). Posterior Pituitary and Water Metabolism. In: Textbook of Endocrinology. Wilson JD, Foster DW, Kronenberg HM, Larsen PR (editors). Philidelphia: W.B.Saunders. pp. 341-375.
299. Reichlin S (1998). Neuroendocrinology. In: Textbook of Endocrinology. Wilson JD, Foster DW, Kronenberg HM, Larsen PR (editors). Philadelphia: W.B.Saunders. pp. 165-248.
300. Richard D, Rivest S, Rivier C. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res 1992; 594:131-137.
301. Richardson Morton KD, Van de Kar LD, Brownfield MS, Lorens SA, Napier TC, Urban JH. Stress-induced renin and corticosterone secretion is mediated by catecholaminergic nerve terminals in the hypothalamic paraventricular nucleus. Neuroendocrinology 1990; 51:320-327.
302. Rittenhouse PA, Bakkum EA, Levy AD, Li Q, Carnes M, Van de Kar LD. Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2Q receptors. J Pharmacol Exp Ther 1994; 271:1647-1655.
303. Rittenhouse PA, Bakkum EA, O'Connor PA, Carnes M, Bethea CL, Van de Kar LD. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HTIA agonist, in three stress paradigms: immobilization, forced swim and conditioned fear. Brain Res 1992; 580:205-214.
304. Rittenhouse PA, Levy AD, Li Q, Bethea CL, Van de Kar LD. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HTIc/2 receptors. Endocrinology 1993; 133:661-667.
305. Rivier C, Chizzonite R, Vale W. In the mouse, the activation of the hypothalamic-pituitary- adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 1989; 125:2800-2805.
306. Rivier C, Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 1983; 113:939-942.
307. Ross SB, Renyi L, Kelder D. N-methyl-D-aspartate receptor antagonists counteract the long lasting 5-HT1A receptor-induced attenuation of postsynaptic responses in the rat in vivo. Naunyn Schmiedebergs Arch Pharmacol 1992; 346:138-143.
308. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ, Jr., Shen Y. Meltzer HY, Sibley DR. Binding of typical and atypical antipsychotic agents to 5- hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994; 268:1403-1410.
309. Roth BL, Hanizavareh SM, Blum AE. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl) 2004: 174:17-24.
310. Routledge C, Gurling J, Ashworth Preece M, Dourish CT. Differential effects of WAY-100135 on the decrease in 5- hydroxytryptamine release induced by buspirone and NAN-190. Fur J Pharmacol 1995; 276:281-284.
311. Ruat M, Traiffort E, Leurs R, Tardivel Lacombe J, Diaz J, Arrang JM, Schwartz JC. Molecular cloning, characterization, and localization of a high- affinity serotonin receptor (5-HT7) activating cAMP formation. PNAS 1993: 90:8547-8551.
312. Rueter LE, Fornal CA, Jacobs BL A. critical review of 5-HT brain microdialysis and behavior. Rev Neurosci 1997; 8:117-137.
313. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V. Corticotropic-releasing hormone and serotonin interact in the human brain-stem: behavioral implications. Neuroscience 1999; 91:1343-1354.
314. Samgin, G. N., Ryan, D. H., De Souza, E. B., and Harris, R. B. S. The role of CRF1 receptors in restraint-, CRF- and urocortin-induced anxiety-like behaviours. Society for Neuroscience 24[1]. 1198. 1998.
315. Samson WK, Taylor MM, Baker JR. Prolactin-releasing peptides. Regul Pept 2003; 114:1-5.
316. Saphier D, Farrar GE, Welch JE. Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists. Psychoneuroendocrinology 1995; 20:239-257.
317. Saphier D, Welch JE. Effects of the serotonin1A agonist, 8-hydroxy-2- (di-n- propylamino)tetralin on neurochemical responses to stress. J Neurochem 1995; 64:767-776.
318. Sawchenko PE, Swanson LW. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 1993; 219:121-144.
319. Sawchenko PE, Swanson LW, Steinbusch HW, Verhofstad AA. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 1983; 277:355-360.
320. Saxena PR. Serotonin receptors: subtypes, functional responses and therapeutic relevance. Pharmacol Ther 1995; 66:339-368.
321. Saydoff JA, Carnes M, Brownfield MS. The role of serotonergic neurons in intravenous hypertonic saline-induced secretion of vasopressin, oxytocin, and ACTH. Brain Res Bull 1993; 32:567-572.
322. Saydoff JA, Rittenhouse PA, Carnes M, Armstrong J, Van de Kar LD. Brownfield MS. Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. Am J Physiol 1996; 270:E513-21.
323. Schechter LE, Simansky KJ. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology Berl 1988; 94:342-346.
324. Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane) -induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 1995: 273:101-112.
325. Selye H. A syndrome produced by diverse nociuous agents. Nature 1936; 138:32.
326. Shen Y, Monsma FJ, Jr., Metcalf MA, Jose PA, Hamblin MW, Sibley DR. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 1993; 268:18200-18204.
327. Shin SH. Prolactin secretion in acute stress is controlled-by prolactin releasing factor. Life Sci 1979; 25:1829-1835.
328. Sills MA, Wolfe BB, Frazer A. Determination of selective and nonselective compounds for the 5- HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 1984; 231:480-487.
329. Spinedi E, Negro Vilar A. Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation
330. Steinbusch HW. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981; 6:557-618.
331. Steinbusch HW, Nieuwenhuys R (1983). The raphe nuclei of the rat brainstem: A cytoarchietectonic and immunohistochemical study. In: Chemical neuroanatomy. Emson PC (editor). New York: Raven Press. pp. 131-207.
332. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci 1995; 771:1-18.
333. Summers CH. Mechanisms for quick and variable responses. Brain Behaviour and Evolution 2001; 57:283-292.
334. Summers CH, Kampshoff JL, Ronan PJ, Lowry CA, Prestbo AA, Korzan WJ, Renner KJ. Monoaminergic activity in subregions of raphe nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor. J Neuroendocrinol 2003; 15:1122-1133.
335. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983; 36:165-186.
336. Thomas DR, Hagan JJ. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004 3:81-90.
337. Tuomisto J, Tuomisto L. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol 1980; 58:33-37.
338. Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its dertermination. Am J Physiol 1953; 175:157-161.
339. Urban JH. Van de Kar LD, Lorens SA, Bethea, CL. Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats. Pharmacol Biochem Behav 1986; 25:457-462.
340. Uvnas-Moberg K, Hillegaart V, Alster P, Ahlenius S. Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat. Neuropharmacology 1996: 35: 1635-1640.
341. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213:1394-1397.
342. Van de Kar LD. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol 1991; 31:289-320.
343. Van de Kar LD, Alvarez Sanz MC, Yracheta JM, Kunímoto K, Li Q, Levy AD, Rittenhouse PA. ICV injection of the serotonin 5-HTIB agonist CP-93, 129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms. Pharmacol Biochem Behav 1994: 48:429-436.
344. Van de Kar LD, Bethea CL. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus. Neuroendocrinology 1982; 35:225-230.
345. Van de Kar LD, Javed A, Zhang Y, Serres F, Raap DK, Gray TS. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 2001; 21:3572-3579.
346. Van de Kar LD, Karteszi M, Bethea CL, Ganong WF. Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus. Neuroendocrinology 1985a; 41:380-384.
347. Van de Kar LD, Levy AD, Li Q, Brownfield MS. A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499). Pharmacol Biochem Behav 1998a:, 60:677-683.
348. Van de Kar LD, Li Q, Cabrera TM, Brownfield MS, Battaglia G. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5.7-dihydroxytryptamine-induced denervation of serotonergic neurons. J Pharmacol Exp Ther 1998b: 286:256-262.
349. Van de Kar LD, Lorens SA, McWilliams CR, Kunimoto K. Urban JH, Bethea CL. Role of midbrain raphe in stress-induced renin and prolactin secretion. Brain Res 1984; 311:333-341.
350. Van de Kar LD, Lorens SA, Urban JH, Bethea CL. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion. Neuropharmacology 1989; 28:299-305.
351. Van de Kar LD, Richardson Morton KD, Rittenhouse PA. Stress: neuroendocrine and pharmacological mechanisms. Methods Achiev Exp Pathol 1991; 14:133-173.
352. Van de Kar LD, Rittenhouse PA, Li Q. Levy AD, Brownfield MS. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res Bull 1995: 36:45-50.
353. Van de Kar LD, Urban JH, Richardson KD, Bethea CL. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterotic secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan. Neuroendocrinology 1985b; 41:283-288.
354. Van de Kar LD, Wilkinson CW, Skrobik Y, Brownfield MS, Ganong WF. Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone. Brain Res 1982; 235:233-243.
355. van Oers JW, Tilders FJ. Antibodies in passive immunization studies: characteristics and consequences. Endocrinology 1991; 128:496-503.
356. Van Riel E, Meijer OC, Steenbergen PJ, Joels M. Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience 2003; 120:649-658.
357. van Wijngaarden I, Tulp MT, Soudijn W. The concept of selectivity in 5-HT receptor research. Eur J Pharmatcol 1990; 188:301-312.
358. Vanhoenacker P, Haegeman G, Leysen JE. 5-HT7 receptors: current knowledge and future prospects. Trends Pharmacol Sci 2000; 21:70-77.
359. Vicentic A, Li Q, Battaglia G, Van de Kar LD. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur J Pharmacol 1998; 346:261-266.
360. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 2001; 69:643-652.
361. Volpi R, Chiodera P, Giuliani N, Capretti L, Caffarri G, Magotti MG, Coiro V. 5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. J Endocrinol Invest 1998; 21:7-11.
362. Watanabe Y, Sakai RR, McEwen BS, Mendelson SD. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 1993; 615:87-94.
363. Weidenfeld J, Feldman S. Itzik A, Van de Kar LD, Newman ME. Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and corticosterone secretion in the rat. Brain Res 2002a; 941:113-117.
364. Weidenfeld J, Newman ME, Itzik A, Gur E, Feldman S. The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic serotonin following electrical stimulation of the dorsal raphe nucleus in the rat. Neuroendocrinology 2002b; 76:63-69.
365. Weiner RI, Findell PR, Kordon C (1988). Role of Classic and Peptide neuromediators in the Neuroendocrine Regulation of LH and Prolactin. In: The Physiology of Reproduction Knobil E, Neill J (editors). New York: Raven Press. pp. 1235-1281.
366. Weiner RI, Ganong WE, Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 1979; 58:905-976.
367. Wigger A, Sanchez MM, Mathys KC, Ebner K, Frank E, Liu D, Kresse A, Neumann ID, Holsboer F, Plotsky PM, Landgraf R. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 2004; 29:1-14.
368. Willems E, Knigge U, Jorgensen H, Kjaer A, Warberg J. Effect of selective blockade of catecholaminergic alpha and beta receptors on histamine-induced release of corticotropin and prolactin. Neuroendocrinology 1999: 69:309-315.
369. Willoughby JO, Menadue ME, Liebelt HJ. Activation of 5-HT 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat. Neuroendocrinology 1988; 47:83-87.
370. Woolley ML, Marsden CA, Fone KC. 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3:59-79.
371. Wotjak CT, Ganster J, Kohl G, Holsboer F, Landgraf R, Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998; 85:1209-1222.
372. Wotjak CT, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neu-ann I, Landgraf R. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion? J Neurosci 1996; 16:7725-7732.
373. Wotjak CT, Naruo T, Muraoka S, Simchen R, Landgraf R, Engelmann M. Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2001; 13:2273-2281.
374. Yagi K, Onaka T. Suppressive vasopressin response to emotional stress: the neuroactive substance that may be involved. Ann N Y Acad Sci 1993; 689:685-688.
375. Yasuda N, Greer MA. Evidence that the hypothalamus mediates endotoxin stimulation of adrenocorticotropic hormone secretion. Endocrinology 1978; 102:947-953.
376. Yau JL, Noble J, Seckl JR. Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci Lett 2001; 309:141-144.
377. Yoshioka M, Matsumoto M, Togashi H, Saito H. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav 1995: 51:515-519.
378. Zhang Y, D'Souza D, Raap DK, Garcia F. Battaglia G, Muma NA, Van de Kar LD. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation. J Neurosci 2001; 21:7919-7927.
379. Zhang Y, Darrjanoska Kj, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci 2002; 22:9635-9642.
380. Zhang Y, Raap DK, Garcia F, Serres F, Ma Q, Battaglia G, Van de Kar LD. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats Brain Res 2000; 855:58-66.
381. Zifa E, Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 1992; 44:401-458.